MRTX - Mirati Therapeutics Inc. (MRTX) CEO David Meek on Q3 2021 Results - Earnings Call Transcript

Mirati Therapeutics, Inc. (MRTX) Q3 2021 Earnings Conference Call November 09, 2021, 04:30 PM ET Company Participants David Meek – CEO Ryan Asay – Vice President of Corporate Affairs at Mirati Charles Baum – President, Founder and Head of Research and Development Dr. James Christensen – Chief Scientific Officer Vickie S. Reed – Chief Accounting Officer Conference Call Participants Gena Wang – Barclays Umer Raffat – Evercore Salveen Richter – Goldman Sachs Anupam Rama – JP Morgan Gabe Daoud – Cowen Michael Schmidt – Guggenheim Yigal Nochomovitz – Citi Maury Raycroft – Jefferies Ben Burnett – Stifel Jason Gerberry – Bank of America Andrew Burns – SVB Leerink Presentation Operator Good afternoon, ladies and gentlemen. Welcome to the Mirati Therapeutics Third Quarter 2021 earnings call. My name is Keith (ph) and I'll be your operator for today's call. All lines have been placed on mute to prevent any background noise.

For further details see:

Mirati Therapeutics, Inc. (MRTX) CEO David Meek on Q3 2021 Results - Earnings Call Transcript